Haematology Research Review, Issue 59

In this issue:

 Long-term leukaemic progression in thrombocytopenic low-risk MDS treated with romiplostim or placebo
 Ruxolitinib after and vs. interferon in RESPONSE studies
 PSE for steroid-resistant chronic ITP
 ITP and CV disease
 Outcomes of previously untreated elderly AML patients
 Melphalan 140 vs. 200 mg/m2 for autologous HSCT in myeloma
 Brentuximab vedotin + nivolumab in relapsed/refractory Hodgkin’s lymphoma
 Primary combination regimens and maintenance rituximab in Waldenström’s
 Musculoskeletal ultrasound for intra-articular bleed detection

Please login below to download this issue (PDF)